Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial
- 31 December 1992
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 22 (1), 225-230
- https://doi.org/10.1016/0360-3016(92)91009-c
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Studies on high grade cerebral gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.BMJ, 1985
- Amplification and overexpression of the egf receptor gene in primary human glioblastomasJournal of Cell Science, 1985
- Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group studyCancer, 1983
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983
- Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980International Journal of Radiation Oncology*Biology*Physics, 1982
- Iodine-125 cytotoxicity: Implications for therapy and estimation of radiation riskInternational Journal of Nuclear Medicine and Biology, 1981
- The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iododeoxyuridine, iodotamoxifen, and iodoantipyrineJournal of Radioanalytical and Nuclear Chemistry, 1981
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- The Radiotoxicity of Iodine-125 in Mammalian Cells: II. A Comparative Study on Cell Survival and Cytogenetic Responses to 125 IUdR, 131 IUdR, and 3 HTdRRadiation Research, 1976